Penumbra, Inc.
Penumbra, Inc. (PEN) Financial Performance & Income Statement Overview
Review Penumbra, Inc. (PEN) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Penumbra, Inc. (PEN) Income Statement & Financial Overview
Review Penumbra, Inc. PEN income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $324.14M | $315.52M | $301.04M | $299.40M |
| Cost of Revenue | $108.26M | $104.80M | $100.73M | $139.06M |
| Gross Profit | $215.88M | $210.72M | $200.31M | $160.34M |
| Gross Profit Ratio | $0.67 | $0.67 | $0.67 | $0.54 |
| R&D Expenses | $22.08M | $20.01M | $25.20M | $24.94M |
| SG&A Expenses | $153.46M | $147.94M | $139.74M | $139.42M |
| Operating Expenses | $175.53M | $167.95M | $164.94M | $164.36M |
| Total Costs & Expenses | $283.79M | $272.74M | $265.68M | $303.42M |
| Interest Income | $3.38M | $3.28M | $3.46M | $3.66M |
| Interest Expense | $322000.00 | $337000.00 | $336000.00 | $344000.00 |
| Depreciation & Amortization | $5.01M | $4.39M | $4.15M | $7.65M |
| EBITDA | $49.20M | $49.06M | $44.26M | -$69.88M |
| EBITDA Ratio | $0.15 | $0.16 | $0.15 | -$0.23 |
| Operating Income | $40.35M | $42.77M | $35.36M | -$4.02M |
| Operating Income Ratio | $0.12 | $0.14 | $0.12 | -$0.01 |
| Other Income/Expenses (Net) | $3.51M | $1.56M | $4.41M | $3.09M |
| Income Before Tax | $43.86M | $44.34M | $39.78M | -$77.87M |
| Income Before Tax Ratio | $0.14 | $0.14 | $0.13 | -$0.26 |
| Income Tax Expense | $4.63M | $10.66M | $10.25M | -$17.67M |
| Net Income | $39.22M | $33.68M | $29.53M | -$60.20M |
| Net Income Ratio | $0.12 | $0.11 | $0.10 | -$0.20 |
| EPS | $1.02 | $0.87 | $0.76 | -$1.55 |
| Diluted EPS | $1.00 | $0.86 | $0.75 | -$1.55 |
| Weighted Avg Shares Outstanding | $38.56M | $38.63M | $38.61M | $38.79M |
| Weighted Avg Shares Outstanding (Diluted) | $39.16M | $39.27M | $39.18M | $38.79M |
The company's financials show resilient growth, with revenue advancing from $299.40M in Q2 2024 to $324.14M in Q1 2025. Gross profit remained healthy with margins at 67% in Q1 2025 compared to 54% in Q2 2024. Operating income hit $40.35M last quarter, sustaining a consistent 12% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $49.20M. Net income rose to $39.22M, while earnings per share reached $1.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan